Community Outreach and Engagement

项目摘要：社区外展和参与 Jackilen Shannon，博士，M.P.H.，社区外展和参与部副主任 奈特癌症研究所(KCI)的社区外联和参与(COE)致力于识别和 通过参与解决我们集水区俄勒冈州癌症负担的差异 与我们的社区和KCI科学家合作。COE根据社区的九项原则模拟我们的工作 参与由有毒物质和疾病登记局定义，并作为 临床和翻译科学奖(CTSA)联盟的社区外联和 参与职能委员会。COE副主任，Jackilen Shannon，Ph.D.，M.P.H.(CPC)和KCI 总监Brian Druker，M.D.(TO)由社区咨询委员会和KCI研究整合中心提供建议 团队并为COE提供更广阔的愿景。蒂法尼·霍华德博士，研究助理总监，负责监督- 接触KCI的科学家，并通过社区伙伴关系倡议进行推广。阿曼达·布鲁格尔，医学博士(CPC) 是临床助理主任，促进临床医生、临床研究和COE之间的沟通。 在KCI和社区之间长期且值得信赖的关系的基础上，COE活动是 由四个目标提供信息：1)通过以下方式确定和监测俄勒冈州的癌症负担和癌症需求 持续收集主要数据，汇总现有数据资源，并促进社区投入；2) 在俄勒冈州开展社区参与的外展活动，以响应癌症需求 我们的集水区人口以满足癌症预防、早期发现、治疗和生存的需求， 以及提高所有人口的代表性，特别是那些不成比例地受到癌症影响的人口；3) 促进与解决所有KCI集水区癌症优先事项相关的研究 计划；以及4)增强社区计划和合作伙伴的能力，以有效地解决其 通过社区拨款、培训和支持，解决社区与癌症相关的最大问题。 在与我们社区的合作中，我们已经确定了优先癌症和行为是乳腺癌， 肺/支气管、结直肠、前列腺癌、黑色素瘤、胰腺癌、白血病/淋巴瘤以及 戒烟和接种HPV疫苗。KCI优先事项的确定是通过仔细注意确定 种族/民族、地域和其他差异，并侧重于增加代表不足的人的参与度 组。COE向KCI领导层和科学家传达与癌症相关的需求和差距；实施 由我们的社区和KCI研究人员共同定义的COE计划；确定社区计划 活动并联合实施癌症教育、筛查和预防计划；向KCI通报和协调 与我们的优先事项研究；并加强我们的能力，以满足社区的癌症研究需求。

PROJECT SUMMARY: Community Outreach and Engagement Jackilen Shannon, Ph.D., M.P.H., Associate Director of Community Outreach and Engagement Community Outreach and Engagement (COE) at the Knight Cancer Institute (KCI) is dedicated to identifying and addressing disparities in cancer burden across our catchment area, the state of Oregon, through engagement with our communities and KCI scientists. COE models our work on the nine Principles of Community Engagement defined by the Agency for Toxic Substances and Disease Registry and developed as part of the work of the Clinical and Translational Science Awards (CTSA) Consortium's Community Outreach and Engagement Function Committee. COE Associate Director, Jackilen Shannon, Ph.D., M.P.H. (CPC), and KCI Director Brian Druker, M.D. (TO) are advised by a Community Advisory Board and the KCI Research Integration Team and provide the broader vision for COE. Tiffani Howard, Ph.D., Research Assistant Director, oversees in- reach to KCI scientists and outreach through the Community Partnership Initiative. Amanda Bruegl, M.D. (CPC) is Clinical Assistant Director and facilitates communication between clinicians, clinical research, and COE. Building on the long-standing and trusted relationships between KCI and the community, COE activities are informed by four objectives: 1) DEFINE and MONITOR the cancer burden and cancer needs in Oregon through ongoing primary data collection, aggregation of existing data resources, and facilitated community input; 2) CONDUCT community-engaged outreach activities responsive to cancer needs in Oregon by engaging with our catchment area population to address cancer prevention, early detection, treatment, and survivorship needs, and to enhance the representation of all populations, particularly those disproportionally impacted by cancer; 3) FACILITATE research relevant to addressing the cancer priorities of the catchment area across all KCI programs; and 4) AMPLIFY the capacity of community programs and partners to effectively address their communities' greatest cancer-related concerns through community grants, training, and support. In collaboration with our community, we have identified priority cancers and behaviors as breast, lung/bronchial, colorectal, prostate, melanoma, pancreatic cancer, and leukemia/lymphoma, as well as tobacco use cessation and HPV vaccination. KCI priorities are identified through careful attention to identifying racial/ethnic, geographic, and other disparities and focusing on increasing engagement of under-represented groups. COE communicates cancer-related needs and disparities to KCI leadership and scientists; implements COE initiatives that are defined jointly by our community and KCI researchers; identifies community program activities and jointly implements cancer education, screening, and prevention programs; informs and aligns KCI research with our priorities; and strengthens our capacity to address cancer research needs in the community.